Reward deficiency syndrome: genetic aspects of behavioral disorders

The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same releas...

Full description

Saved in:
Bibliographic Details
Published inProgress in Brain Research Vol. 126; pp. 325 - 341
Main Authors Comings, David E., Blum, Kenneth
Format Book Chapter Journal Article
LanguageEnglish
Published Netherlands Elsevier Science & Technology 2000
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by ‘unnatural rewards’ such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compuslive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates.
AbstractList The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders.
The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders.The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders.
The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called ‘natural rewards’ and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by ‘unnatural rewards’ such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compuslive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates.
Author Comings, David E.
Blum, Kenneth
Author_xml – sequence: 1
  givenname: David E.
  surname: Comings
  fullname: Comings, David E.
  email: dcomings@earthlink.net
  organization: Department of Medical Genetics, City of Hope Medical Center, Duarte, CA 91010, USA
– sequence: 2
  givenname: Kenneth
  surname: Blum
  fullname: Blum, Kenneth
  organization: Department of Biological Sciences, University of North Texas, Denton TX 76203 and Department of Clinical Sciences, PATH Medical Foundation, New York, NY, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11105655$$D View this record in MEDLINE/PubMed
BookMark eNo9kMlOwzAQQC0oogv9BFBOCA6BsR07CReEKjapEhLL2XLsCRhlKXZa1L8nLYXTXN6M5r0xGTRtg4QcU7igQOXlC0Cax5IyfgZwziQwFss9MqJZKuI0E2KfTPM0gyRJBHDO8gEZ_a8MyTiETwCW5pAckiGlFIQUYkRmz_itvY0sls44bMw6CuvG-rbGq-gdG-yciXRYoOlC1JZRgR965Vqvq8i60HqLPhyRg1JXAae7OSFvd7evs4d4_nT_OLuZx8gk72Jt0SYl17IUUgMgz1LOrDGQacw0LwwrUWfALDMFyIIClqVMtC2yXIIUmk_I6e_dhW-_lhg6VbtgsKp0g-0yqJQlggvGe_BkBy6LGq1aeFdrv1Z_2j1w_Qtg_-7KoVdhK4_W-d5U2dYpCmoTXm3Dq01FBaC24ZXkP1GNdFk
ContentType Book Chapter
Journal Article
Copyright 2000
Copyright_xml – notice: 2000
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S0079-6123(00)26022-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1875-7855
EndPage 341
ExternalDocumentID 11105655
S0079612300260226
Genre Journal Article
Review
GroupedDBID ---
--K
-~X
.55
0R~
123
3O-
53G
5RE
8NA
8NC
8NF
AAPMF
AAXUO
AAYSV
ABGWT
ABMAC
ABQQC
ACGFS
ACXMD
AENEX
AFFNX
AFOST
AFTJW
AGAMA
AHPSJ
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
DU5
EBS
EJD
F5P
FDB
FEDTE
HVGLF
HZ~
JDP
L7B
O9-
P2P
RIG
SBF
SDK
SES
SHL
X7M
ZGI
ZXP
AALRI
ADVLN
AHMUE
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-e263t-aded4f3a6f56a00e38732dcc08ae8a3bc2fea802d2cb06b10eff64adb896065a3
ISBN 9780444503329
0444503323
ISSN 0079-6123
IngestDate Fri Jul 11 04:35:22 EDT 2025
Sat Sep 28 07:34:59 EDT 2024
Fri Feb 23 02:34:14 EST 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-e263t-aded4f3a6f56a00e38732dcc08ae8a3bc2fea802d2cb06b10eff64adb896065a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 11105655
PQID 72453523
PQPubID 23479
PageCount 17
ParticipantIDs proquest_miscellaneous_72453523
pubmed_primary_11105655
elsevier_sciencedirect_doi_10_1016_S0079_6123_00_26022_6
PublicationCentury 2000
PublicationDate 2000
2000-00-00
20000101
PublicationDateYYYYMMDD 2000-01-01
PublicationDate_xml – year: 2000
  text: 2000
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Progress in Brain Research
PublicationTitleAlternate Prog Brain Res
PublicationYear 2000
Publisher Elsevier Science & Technology
Publisher_xml – name: Elsevier Science & Technology
SSID ssj0027904
ssj0000782502
Score 2.1953442
SecondaryResourceType review_article
Snippet The dopaminergic and opiodergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and...
The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and...
SourceID proquest
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 325
SubjectTerms Attention Deficit Disorder with Hyperactivity - genetics
Behavior, Addictive - genetics
Carrier Proteins - genetics
Carrier Proteins - physiology
Central Nervous System Stimulants - pharmacology
Compulsive Behavior - genetics
Dangerous Behavior
Dopamine beta-Hydroxylase - genetics
Exploratory Behavior
Genetic Heterogeneity
Genetic Predisposition to Disease
Humans
Impulsive Behavior - genetics
Models, Neurological
Monoamine Oxidase - genetics
Neurotransmitter Agents - metabolism
Neurotransmitter Agents - physiology
Nucleus Accumbens - drug effects
Nucleus Accumbens - physiology
Opioid Peptides - genetics
Opioid Peptides - physiology
Polymorphism, Restriction Fragment Length
Prefrontal Cortex - drug effects
Prefrontal Cortex - physiology
Receptors, Adrenergic - drug effects
Receptors, Adrenergic - genetics
Receptors, Cannabinoid
Receptors, Dopamine D2 - drug effects
Receptors, Dopamine D2 - genetics
Receptors, Dopamine D2 - physiology
Receptors, Dopamine D4
Receptors, Drug - drug effects
Receptors, Drug - genetics
Receptors, Neurotransmitter - drug effects
Receptors, Neurotransmitter - genetics
Receptors, Neurotransmitter - physiology
Reward
Satiation - physiology
Self Stimulation - physiology
Stress Disorders, Post-Traumatic - genetics
Stress Disorders, Post-Traumatic - physiopathology
Substance-Related Disorders - genetics
Tourette Syndrome - genetics
Tourette Syndrome - physiopathology
Title Reward deficiency syndrome: genetic aspects of behavioral disorders
URI https://dx.doi.org/10.1016/S0079-6123(00)26022-6
https://www.ncbi.nlm.nih.gov/pubmed/11105655
https://www.proquest.com/docview/72453523
Volume 126
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ywVxKZTH8vQBIVCV4rUTx8ttVbWqqOBQWtqb5cSOxKEJotkD_HpmbMfZXeBAL9lVFG3smdnxfOOZz4S8xs02WwiZgaurstywPDMCwcqchxMh5373_NNneXKRf7wqriaTZq1qadVXB_Wvv_aV3EarcA_0il2y_6HZ9KNwA76DfuEKGobrVvC7mWYNpBdYWYV-6lsLGgKAn6ro0r5Cd4158FS6vn90kNB3PN84tuWsG86Zw0LafeuQW8I3Zg6sBpg9gOE4z_HqWzR9Hchap7-NXJ6byQS2lUxIXS6DY0Hz28rxD9gTieZwDzQmLKJ_LRcZErqE1SW4VEBEWakCGW_yuXzda4rQ-xwXYBGYsP7w7SHN8CW9AyJwPMh6AYgMAPUWn7Zfof2z-KhnToNAc4fswEim5M5y-fXyOOXiMEwqGB-B-oIF9u74Js9kEGcrBtamYfZjW9j7cWxvGXsXx7UR5fwLxfho5nyX3MMOF4qtJzCP-2Ti2gdkb9mavrv-Sd9QXxXsVbFHDoM50NEc6GAOH2g0BhqNgXYNHY2BJmN4SC6Oj84PT7J48EbmuBR9ZqyzeSOMbAppGHNClYLbumbKOGVEVfPGGcW45XXFZDVnrmlkbmylEA8XRjwi07Zr3RNCS66q2hgJIlV5hQEorPTIRyFYrawoZkQN0tEx5guxnAa167EEEQSrUbCaMe0Fq-WMvBqkqcEn4kaXaV23utElz5G1SMzI4yBk_T1QtyDehYi_KJ7e_rXPyN3xn_OcTPsfK_cCAtO-ehntCj9Pzy5PfwNqH4DW
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Brain+Research&rft.au=Comings%2C+David+E.&rft.au=Blum%2C+Kenneth&rft.atitle=Reward+deficiency+syndrome%3A+genetic+aspects+of+behavioral+disorders&rft.date=2000-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780444503329&rft.issn=0079-6123&rft.eissn=1875-7855&rft.volume=126&rft.spage=325&rft.epage=341&rft_id=info:doi/10.1016%2FS0079-6123%2800%2926022-6&rft.externalDocID=S0079612300260226
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0079-6123&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0079-6123&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0079-6123&client=summon